Robotics-related deals in the pharmaceutical industry increased in H1 2021
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Robotics-related deals in the pharmaceutical industry increased in H1 2021

By Saywah Mahmood 17 Nov 2021 (Last Updated November 17th, 2021 17:35)

Robotics-related deals made up 0.6% of all deals announced in the pharma sector in H1 2021.

Robotics-related deals in the pharmaceutical industry increased in H1 2021
Credit: Shutterstock

Robotics-related deals made up 0.6% of all deals announced in the pharmaceutical sector in the first six months of 2021.

This represents an increase from the figure of 0.3% in the last six months of 2020 and a decrease from 0.7% in the first six months of 2020.

GlobalData’s deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.

In the first six months of 2021, the overall number of announced deals in the pharmaceutical sector increased by 8.6%, from the same period in 2020.

GlobalData's thematic approach to sector activity seeks to group key company information on investments to see which industries are best placed to deal with any issues they may encounter.

These themes, of which robotics is one, are best thought of as "any issue that keeps a CEO awake at night", and by tracking them, it becomes possible to ascertain which companies are leading the way on specific issues and which ones have some work to do.